Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG

被引:319
作者
Carter, Stephen F.
Scholl, Michael
Almkvist, Ove [2 ]
Wall, Anders [3 ]
Engler, Henry [3 ,4 ]
Langstrom, Bengt [5 ,6 ]
Nordberg, Agneta [1 ,7 ]
机构
[1] Karolinska Inst, Div Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, S-14186 Stockholm, Sweden
[2] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden
[3] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden
[4] Uruguayan Ctr Mol Imaging CUDIM, Montevideo, Uruguay
[5] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden
[6] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Neuropsychopharmacol Unit, London, England
[7] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Alzheimer disease; mild cognitive impairment; PET; astrocytosis; amyloid; monoamine oxidase B; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; MONOAMINE-OXIDASE-B; HUMAN-BRAIN; MAO-B; CLINICAL PROGRESSION; MICROGLIA; INHIBITOR; DIAGNOSIS; HEALTH;
D O I
10.2967/jnumed.110.087031
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Astrocytes colocalize with fibrillar amyloid-beta (A beta) plaques in postmortem Alzheimer disease (AD) brain tissue. It is therefore of great interest to develop a PET tracer for visualizing astrocytes in vivo, enabling the study of the regional distribution of both astrocytes and fibrillar A beta. A multitracer PET investigation was conducted for patients with mild cognitive impairment (MCI), patients with mild AD, and healthy controls using C-11-deuterium-L-deprenyl (C-11-DED) to measure monoamine oxidase B located in astrocytes. Along with C-11-DED PET, C-11-Pittsburgh compound B (C-11-PIB; fibrillar A beta deposition), F-18-FDG (glucose metabolism), T1 MRI, cerebrospinal fluid, and neuropsychologic data were acquired from the patients. Methods: C-11-DED PET was performed in MCI patients (n = 8; mean age 6 SD, 62.6 +/- 7.5 y; mean Mini Mental State Examination, 27.5 +/- 2.1), AD patients (n = 7; mean age, 65.1 +/- 6.3 y; mean Mini Mental State Examination, 24.4 +/- 5.7), and healthy age-matched controls (n = 14; mean age, 64.7 +/- 3.6 y). A modified reference Patlak model, with cerebellar gray matter as a reference, was chosen for kinetic analysis of the C-11-DED data. C-11-DED data from 20 to 60 min were analyzed using a digital brain atlas. Mean regional F-18-FDG uptake and C-11-PIB retention were calculated for each patient, with cerebellar gray matter as a reference. Results: ANOVA analysis of the regional C-11-DED binding data revealed a significant group effect in the bilateral frontal and bilateral parietal cortices related to increased binding in the MCI patients. All patients, except 3 with MCI, showed high C-11-PIB retention. Increased C-11-DED binding in most cortical and subcortical regions was observed in MCI C-11-PIB+ patients relative to controls, MCI C-11-PIB (negative) patients, and AD patients. No regional correlations were found between the 3 PET tracers. Conclusion: Increased C-11-DED binding throughout the brain of the MCI C-11-PIB+ patients potentially suggests that astrocytosis is an early phenomenon in AD development.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 39 条
[11]   Age-related increases in brain monoamine oxidase B in living healthy human subjects [J].
Fowler, JS ;
Volkow, ND ;
Wang, GJ ;
Logan, J ;
Pappas, N ;
Shea, C ;
Macgregor, R .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :431-435
[12]   MONOAMINE OXIDASE-B (MAO-B) INHIBITOR THERAPY IN PARKINSONS-DISEASE - THE DEGREE AND REVERSIBILITY OF HUMAN BRAIN MAO-B INHIBITION BY RO 19 6327 [J].
FOWLER, JS ;
VOLKOW, ND ;
LOGAN, J ;
SCHLYER, DJ ;
MACGREGOR, RR ;
WANG, GJ ;
WOLF, AP ;
PAPPAS, N ;
ALEXOFF, D ;
SHEA, C ;
GATLEY, SJ ;
DORFLINGER, E ;
YOO, K ;
MORAWSKY, L ;
FAZZINI, E .
NEUROLOGY, 1993, 43 (10) :1984-1992
[13]   MAPPING HUMAN-BRAIN MONOAMINE OXIDASE-A AND OXIDASE-B WITH C-11 LABELED SUICIDE INACTIVATORS AND PET [J].
FOWLER, JS ;
MACGREGOR, RR ;
WOLF, AP ;
ARNETT, CD ;
DEWEY, SL ;
SCHLYER, D ;
CHRISTMAN, D ;
LOGAN, J ;
SMITH, M ;
SACHS, H ;
AQUILONIUS, SM ;
BJURLING, P ;
HALLDIN, C ;
HARTVIG, P ;
LEENDERS, KL ;
LUNDQVIST, H ;
ORELAND, L ;
STALNACKE, CG ;
LANGSTROM, B .
SCIENCE, 1987, 235 (4787) :481-485
[14]   Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography [J].
Gulyas, Balazs ;
Pavlova, Elena ;
Kasa, Peter ;
Gulya, Karoly ;
Bakota, Lidia ;
Varszegi, Szilvia ;
Keller, Eva ;
Horvath, Monika Csilla ;
Nag, Sangram ;
Hermecz, Istvan ;
Magyar, Kalman ;
Halldin, Christer .
NEUROCHEMISTRY INTERNATIONAL, 2011, 58 (01) :60-68
[15]   Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe [J].
Hammers, A ;
Allom, R ;
Koepp, MJ ;
Free, SL ;
Myers, R ;
Lemieux, L ;
Mitchell, TN ;
Brooks, DJ ;
Duncan, JS .
HUMAN BRAIN MAPPING, 2003, 19 (04) :224-247
[16]   Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356
[17]   Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301 [J].
Hirvonen, J. ;
Kailajarvi, M. ;
Haltia, T. ;
Koskimies, S. ;
Nagren, K. ;
Virsu, P. ;
Oikonen, V. ;
Sipilae, H. ;
Ruokoniemi, P. ;
Virtanen, K. ;
Scheinin, M. ;
Rinne, J. O. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) :506-512
[18]   Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease [J].
Ikonomovic, Milos D. ;
Klunk, William E. ;
Abrahamson, Eric E. ;
Mathis, Chester A. ;
Price, Julie C. ;
Tsopelas, Nicholas D. ;
Lopresti, Brian J. ;
Ziolko, Scott ;
Bi, Wenzhu ;
Paljug, William R. ;
Debnath, Manik L. ;
Hope, Caroline E. ;
Isanski, Barbara A. ;
Hamilton, Ronald L. ;
DeKosky, Steven T. .
BRAIN, 2008, 131 :1630-1645
[19]   Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET [J].
Johansson, Anders ;
Engler, Henry ;
Blomquist, Gunnar ;
Scott, Berit ;
Wall, Anders ;
Aquilonius, Sten-Magnus ;
Langstrom, Bengt ;
Askmark, Hakan .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 255 (1-2) :17-22
[20]   CEREBRAL PERFUSION IMAGING IN ALZHEIMERS-DISEASE - USE OF SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY AND IOFETAMINE HYDROCHLORIDE-I-123 [J].
JOHNSON, KA ;
MUELLER, ST ;
WALSHE, TM ;
ENGLISH, RJ ;
HOLMAN, BL .
ARCHIVES OF NEUROLOGY, 1987, 44 (02) :165-168